en

PRODUCT DETAIL

Caelyx pegylated liposomal 2 mg/ml infúzny koncentrát

Code 13772
MA number EU/1/96/011/003
Product Form: con inf 1x25 ml (liek.inj.skl.)
MA Status: E - Valid centralised marketing authorisation
Type of procedure: EU
Therapeutic Class: 44 - CYTOSTATICA
ATC:
L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L01 ANTINEOPLASTIC AGENTS
L01D CYTOTOXIC ANTIBIOTICS AND RELATED SUBSTANCES
L01DB Anthracyclines and related substances
L01DB01 Doxorubicin
Shelf life: 20
Container: glass vial
Route of admin.: Intravenous use
Prescription Status: Medicinal product subject to restricted medical prescription.
Legal basis: Article 8(3) application
MA issued: 21.06.1996
SmPC + PL: European Medicines Agency's database
Dokument: DHCP Caelyx 18 10 12.pdf  
Dokument: DHPC Caelyx 25 11 2011.pdf  
SPC: CAELYX_texty_marec 2020.pdf  
Safety feature Yes
Data update: 09.03.2021
eu-flag.png sk-flag.png